OvaScience Inc (NASDAQ:OVAS) CEO Michelle Dipp purchased 59,700 shares of the stock in a transaction that occurred on Friday, March 18th. The shares were purchased at an average price of $8.26 per share, with a total value of $493,122.00. Following the completion of the acquisition, the chief executive officer now directly owns 971,921 shares in the company, valued at $8,028,067.46. The purchase was disclosed in a filing with the SEC, which is available through this link.

Michelle Dipp also recently made the following trade(s):

On Wednesday, March 16th, Michelle Dipp purchased 59,029 shares of OvaScience stock. The shares were purchased at an average price of $7.90 per share, with a total value of $466,329.10.
On Monday, March 14th, Michelle Dipp purchased 162,732 shares of OvaScience stock. The shares were purchased at an average price of $7.60 per share, with a total value of $1,236,763.20.
Shares of OvaScience Inc (NASDAQ:OVAS) traded up 6.52% on Monday, hitting $9.31. 138,650 shares of the company traded hands. The firm’s market capitalization is $253.98 million. The firm’s 50-day moving average is $6.49 and its 200 day moving average is $10.38. OvaScience Inc has a 1-year low of $4.53 and a 1-year high of $55.69.

OvaScience (NASDAQ:OVAS) last posted its earnings results on Thursday, February 25th. The company reported ($0.76) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.71) by $0.05. On average, analysts anticipate that OvaScience Inc will post ($2.79) earnings per share for the current fiscal year.

OVAS has been the subject of several research reports. Credit Suisse initiated coverage on shares of OvaScience in a report on Wednesday, January 20th. They issued an “underperform” rating for the company. HC Wainwright restated a “buy” rating and issued a $15.00 price objective on shares of OvaScience in a report on Wednesday, February 17th. Zacks Investment Research upgraded shares of OvaScience from a “sell” rating to a “hold” rating in a report on Saturday, January 9th. Finally, Oppenheimer lowered shares of OvaScience from an “outperform” rating to a “market perform” rating in a report on Monday, January 25th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $20.00.

An institutional investor recently raised its position in OvaScience stock. DIAM Co. Ltd. increased its position in shares of OvaScience Inc (NASDAQ:OVAS) by 0.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 296,434 shares of the company’s stock after buying an additional 2,209 shares during the period. DIAM Co. Ltd. owned about 1.09% of OvaScience worth $2,970,000 as of its most recent SEC filing.

OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of new fertility treatments based on egg precursor or EggPC cells, which are immature egg cells found in the protective outer layer of a woman’s own ovaries. With the Company’s AUGMENT treatment, energy-producing mitochondria from a patient’s own EggPC cells are added to the patient’s mature eggs during the In vitro fertilization (NASDAQ:OVAS) process to supplement the existing mitochondria.

 

Source: American Banking and Market News

NEW YORK (TheStreet) — The Valspar Corp. (VAL – Get Report) stock is advancing 28% to $107.30 in pre-market trading on Monday after the Minneapolis-based paint company agreed to be acquired by its competitor The Sherwin-Williams Co. (SHW) in a deal valued at $11.3 billion.

Shares of Sherwin-Williams are down 0.27% to $287.90 in pre-market trading this morning.

On Sunday, the companies announced the transaction, which is expected to close by the end of the 2017 first quarter and is subject to shareholder and regulatory approval.

Cleveland-based Sherwin-Williams will pay Valspar shareholders $113 per share, representing a 35% premium to Valspar’s stock closing price on Friday, according to Deutsche Bank analysts.

The offer is expected to be the best Valspar will receive after being an acquisition target in the paint industry for some time, Deutsche Bank said in an analyst note this morning.

Annual synergies are estimated to reach $320 million within two years after closing, Sherwin-Williams CEO John Morikis said in a statement.

“We expect this transaction to be immediately accretive excluding one-time costs and meaningfully enhance our cash flow generation profile,” Morikis added.

Separately, Valspar has a “buy” rating and a letter grade of B at TheStreet Ratings because of the company’s good cash flow from operations and expanding profit margins.
TheStreet Ratings objectively rated this stock according to its “risk-adjusted” total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer’s view or that of this article’s author.

 

Source: The Street

NEW YORK (TheStreet) — China HGS Real Estate (HGSH – Get Report)HGSH was gaining 69.4% to $5.86 Tuesday after signing its first shanty area rebuilding agreement with the Hantai District government of Hanzhong City.

Under the agreement the company will develop the shanty areas around Liang Zhou Road in the Hantai District. The local government will work with China HGS to implement the reform plan for the area. About $580 million will be invested in the project.

TheStreet Ratings team rates CHINA HGS REAL ESTATE INC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

“We rate CHINA HGS REAL ESTATE INC (HGSH) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and notable return on equity. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow, poor profit margins and a generally disappointing performance in the stock itself.”

Highlights from the analysis by TheStreet Ratings Team goes as follows:

HGSH’s very impressive revenue growth greatly exceeded the industry average of 10.2%. Since the same quarter one year prior, revenues leaped by 157.2%. Growth in the company’s revenue appears to have helped boost the earnings per share.
CHINA HGS REAL ESTATE INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, CHINA HGS REAL ESTATE INC increased its bottom line by earning $0.46 versus $0.11 in the prior year.
HGSH’s debt-to-equity ratio is very low at 0.29 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Even though the company has a strong debt-to-equity ratio, the quick ratio of 0.13 is very weak and demonstrates a lack of ability to pay short-term obligations.
The gross profit margin for CHINA HGS REAL ESTATE INC is currently lower than what is desirable, coming in at 33.12%. It has decreased from the same quarter the previous year. Despite the weak results of the gross profit margin, the net profit margin of 28.67% has significantly outperformed against the industry average.
Net operating cash flow has significantly decreased to -$3.65 million or 2084.23% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm’s growth rate is much lower.

Source: The Street

 

(NASDAQ: SPEX) Full analyst report below

About Broad Street Alerts:

 

Big opportunities in Small Cap’s in a down market

 

Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.

 

December 29th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.

 

December 15th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.

 

December 2nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.

 

February 14th, 2016 – ETN (NYSEMKT: UWTI) opened at $15.50 per share and is now up nearly 100% for our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Due Diligence Report: Surprise For Earnings Report: Possible and Likely

 

Summary:

 

Spherix Incorporated (Spherix), incorporated on May 1, 1992, is an intellectual property company that owns patented and unpatented intellectual property. The Company is a patent commercialization company that realizes revenue from the monetization of intellectual property. Such monetization includes, but is not limited to, acquiring intellectual property from patent holders and in conducting and managing a licensing campaign. The Company’s activities generally include the acquisition and development of patents through internal or external research and development. In addition, the Company seeks to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications, both in the United States and abroad. The Company develops products and processes associated with its intellectual property and license its intellectual property to others seeking to develop products or processes or whose products or processes infringe its intellectual property rights through legal processes. Some patent holders tend to have limited internal resources and/or expertise to address the unauthorized use of their patented technologies or they simply make the business decision to outsource their intellectual property licensing. They can include individual inventors, large corporations, universities, research laboratories and hospitals

 

Spherix Incorporated has a current market capitalization of $4.95 M with 2.55 M outstanding shares. Its daily average volume traded is 129,195 shares.

Financial Highlights (Q3 2015):

Revenue: Nil

Gross Profit: Nil

Net Income: -2.73 M

Cash and Cash Equivalents: 0.93 M

Total Debt: 0.45 M

Recent News and Analysis:

The company recently announced that the Company had executed an additional agreement to monetize the Nortel patents with Equitable IP Corporation, a leading patent enforcement and monetization fund. Following the initial agreement with Equitable to collaborate on the monetization of the CompuFill patent portfolio, Spherix has signed a new agreement with Equitable, involving the monetization of certain Nortel and North South assets. The Company believes there is widespread infringement of these patents and the total addressable market for the Nortel patents exceeds $50 Billion. The new agreement not only focuses on an extremely valuable portion of the Spherix portfolio, but it also awards economic incentives to Equitable for expeditiously commencing litigation.

Anthony Hayes, CEO of Spherix, said, “We are pleased to announce an additional agreement with our partners at Equitable. This cooperative effort will allow Spherix and Equitable to work together to monetize the substantial value of our patent portfolio. By commencing their work and legal initiatives before May 1, 2016, Equitable will be the beneficiary of a measured yet robust incentive arrangement. Of the 10 new suits that we expect to file, at least seven must apply to the Nortel patents, while two must be against licensees that have public market capitalizations in excess of $1 billion.  As stated in our recent shareholder letter, this new agreement helps to broaden potential revenue generation for our shareholders.”

The institutional sentiment decreased to 0.38 in Q3 2015. It’s down 0.29, from 0.67 in 2015Q2. The ratio dived, as 4 funds sold all Spherix Inc shares owned while 4 reduced positions. 2 funds bought stakes while 1 increased positions. They now own 293,585 shares or 69.32% less from 956,796 shares in 2015Q2. Citadel Advisors LLC holds 0% of its portfolio in Spherix Inc. for 61,372 shares. Citigroup Inc. owns 48 shares or 0% of their US portfolio. Moreover, Creative Planning has 0% invested in the company for 4 shares. The Massachusetts-based Geode Capital Management LLC has invested 0% in the stock. Goldman Sachs Group Inc., a New York-based fund reported 59,267 shares.

Conclusions:

The stock decreased 10.91% or $0.24 on March 18, hitting $1.96. About 195,018 shares traded hands. Spherix Inc. (NASDAQ: SPEX) has declined 87.84% in the last 52 weeks and is downtrending. It has underperformed the S7P 500 by 49.03%. The move comes after 5 months negative chart setup for the $4.45 million company. Analysts have a $1.91 PT which indicates a downside of about 2.55%. However, analysts are awaiting earnings to be reported on April 4h. Given the recent news and indication of revenue generation beginning in the near future, it is not wild to assume the company may surprise with the earnings report. However, it is difficult to predict how much revenue the company will generate leading to difficulty in estimating a price target for the company. The price has declined, but there is a real business behind the unimpressive financials that will produce free cash flow in the future.

Sources:

1. http://www.reuters.com/finance/stocks/companyProfile?rpc=66&symbol=SPEX.O
2. https://www.google.ca/finance?q=NASDAQ%3ASPEX&hl=en&gl=ca&ei=t4DsVpniMNWyjAGe-r6QBA
3. http://finance.yahoo.com/q?s=spex&ql=1
4. https://www.google.ca/finance?q=NASDAQ%3ASPEX&fstype=ii&hl=en&gl=ca&ei=yIDsVrmTK4SA2AaLz7vwCA
5. http://finance.yahoo.com/news/spherix-executes-joint-venture-agreement-123000859.html
6. http://www.smallcapwired.com/can-spherix-incs-tomorrow-be-different-the-stock-declines-again/88531/

 

 

 

 

 

Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it, and I have no business relationship with any company whose stock is mentioned in the article. I reserve the right to sell the redistribution rights to this report for up to two hundred fifty dollars/news source.

The information contained herein is not intended to be investment advice and does not constitute any form of invitation or inducement by Robert Borowski, MSc. to engage in investment activity. Neither the information nor any opinion expressed constitutes a solicitation for the purchase or sale of any security. Securities, financial instruments, strategies, or commentary mentioned herein may not be suitable for all investors and this material is not intended for any specific investor and does not take into account an investor’s particular investment objectives, financial situations or needs. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only current as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fluctuate, and an investor may, upon selling an investment lose a portion of, or the entire principal amount invested. Past performance is no guarantee of future results. Before acting on any recommendation in this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice.

DISCLAIMER

Broad Street Alerts has compensated the author of this report up to two hundred and fifty dollars for the redistribution rights for a period of up to 30 days.

BroadStreetAlerts.com is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC.

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We have been compensated fifteen thousand dollars by Star Media LLC for this and other media / investor relations services for SPEX. We have no positions in SPEX and do not intend to initiate any positions. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

PLEASE NOTE WELL: SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold SCS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.

SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. SCS LLC is not a Broker/Dealer and does not engage in high frequency trading.

 

 

Adobe Systems Incorporated ( ADBE) is reporting for the quarter ending February 29, 2016. The computer software company’s consensus earnings per share forecast from the 3 analysts that follow the stock is $0.47. This value represents a 74.07% increase compared to the same quarter last year. In the past year ADBE has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2016 Price to Earnings ratio for ADBE is 40.82 vs. an industry ratio of 6.50, implying that they will have a higher earnings growth than their competitors in the same industry.

Turquoise Hill Resources Ltd. ( TRQ) is reporting for the quarter ending December 31, 2015. The mining company’s consensus earnings per share forecast from the 1 analyst that follows the stock is $0.05. This value represents a 16.67% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2015 Price to Earnings ratio for TRQ is 19.00 vs. an industry ratio of -6.30, implying that they will have a higher earnings growth than their competitors in the same industry.

Shoe Carnival, Inc. ( SCVL) is reporting for the quarter ending January 31, 2016. The retail (shoe) company’s consensus earnings per share forecast from the 2 analysts that follow the stock is $0.14. This value represents a 6.67% decrease compared to the same quarter last year. SCVL missed the consensus earnings per share in the 4th calendar quarter of 2015 by -2.08%. Zacks Investment Research reports that the 2016 Price to Earnings ratio for SCVL is 17.50 vs. an industry ratio of 12.00, implying that they will have a higher earnings growth than their competitors in the same industry.

New York & Company, Inc. ( NWY) is reporting for the quarter ending January 31, 2016. The retail (shoe) company’s consensus earnings per share forecast from the 2 analysts that follow the stock is $0.01. This value represents a 200.00% increase compared to the same quarter last year. In the past year NWY and beat the expectations the other quarter. Zacks Investment Research reports that the 2016 Price to Earnings ratio for NWY is -88.00 vs. an industry ratio of 12.00.

eMagin Corporation ( EMAN) is reporting for the quarter ending December 31, 2015. The consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.05. EMAN reported earnings of $-0.07 per share for the same quarter a year ago; representing a a decrease of -28.57%.

Bovie Medical Corporation ( BVX) is reporting for the quarter ending December 31, 2015. The consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.06. BVX reported earnings of $-0.12 per share for the same quarter a year ago; representing a a decrease of -50.00%.

Capricor Therapeutics, Inc. ( CAPR) is reporting for the quarter ending December 31, 2015. The medical products company’s consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.19. This value represents a 18.75% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2015 Price to Earnings ratio for CAPR is -3.13 vs. an industry ratio of 5.70.

Aeropostale Inc ( ARO) is reporting for the quarter ending January 31, 2016. The retail (shoe) company’s consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.14. This value represents a 1500.00% decrease compared to the same quarter last year. ARO missed the consensus earnings per share in the 2nd calendar quarter of 2015 by -1.82%. Zacks Investment Research reports that the 2016 Price to Earnings ratio for ARO is -0.31 vs. an industry ratio of 12.00.

Read more: http://www.nasdaq.com/article/after-hours-earnings-report-for-march-17-2016-adbe-trq-scvl-nwy-eman-bvx-capr-aro-cm594615#ixzz43Gpsjdyl

 

Source – NASDAQ.com